Patton Albertson Miller Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Hold |
5,130
| – | – | 0.05% | 176 |
|
|
2025
Q1 | $356K | Sell |
5,130
-350
| -6% | -$24.3K | 0.05% | 167 |
|
|
2024
Q4 | $471K | Sell |
5,480
-240
| -4% | -$20.6K | 0.06% | 152 |
|
|
2024
Q3 | $681K | Sell |
5,720
-180
| -3% | -$21.4K | 0.09% | 133 |
|
|
2024
Q2 | $842K | Sell |
5,900
-80
| -1% | -$11.4K | 0.12% | 118 |
|
|
2024
Q1 | $768K | Sell |
5,980
-200
| -3% | -$25.7K | 0.12% | 120 |
|
|
2023
Q4 | $639K | Sell |
6,180
-200
| -3% | -$20.7K | 0.11% | 132 |
|
|
2023
Q3 | $580K | Sell |
6,380
-300
| -4% | -$27.3K | 0.11% | 141 |
|
|
2023
Q2 | $541K | Sell |
6,680
-952
| -12% | -$77K | 0.1% | 145 |
|
|
2023
Q1 | $607K | Sell |
7,632
-2,068
| -21% | -$165K | 0.11% | 148 |
|
|
2022
Q4 | $656K | Sell |
9,700
-550
| -5% | -$37.2K | 0.12% | 141 |
|
|
2022
Q3 | $511K | Hold |
10,250
| – | – | 0.11% | 151 |
|
|
2022
Q2 | $571K | Sell |
10,250
-1,000
| -9% | -$55.7K | 0.12% | 149 |
|
|
2022
Q1 | $625K | Sell |
11,250
-900
| -7% | -$50K | 0.11% | 161 |
|
|
2021
Q4 | $680K | Sell |
12,150
-320
| -3% | -$17.9K | 0.11% | 158 |
|
|
2021
Q3 | $599K | Sell |
12,470
-2,330
| -16% | -$112K | 0.11% | 158 |
|
|
2021
Q2 | $620K | Sell |
14,800
-750
| -5% | -$31.4K | 0.14% | 127 |
|
|
2021
Q1 | $524K | Sell |
15,550
-834
| -5% | -$28.1K | 0.13% | 138 |
|
|
2020
Q4 | $615K | Sell |
16,384
-166
| -1% | -$6.23K | 0.15% | 129 |
|
|
2020
Q3 | $575K | Hold |
16,550
| – | – | 0.16% | 126 |
|
|
2020
Q2 | $542K | Hold |
16,550
| – | – | 0.16% | 136 |
|
|
2020
Q1 | $498K | Sell |
16,550
-1,550
| -9% | -$46.6K | 0.17% | 135 |
|
|
2019
Q4 | $524K | Hold |
18,100
| – | – | 0.14% | 158 |
|
|
2019
Q3 | $468K | Sell |
18,100
-82
| -0.5% | -$2.12K | 0.13% | 165 |
|
|
2019
Q2 | $457K | Buy |
+18,182
| New | +$457K | 0.13% | 161 |
|